Hollings Cancer Center

home / authors / hollings-cancer-center

Articles

Raymond N. DuBois

New Discovery Enhances Understanding of Colorectal Cancer

Hollings Cancer Center
January 3rd 2022

MUSC Hollings Cancer Center researchers discovered a novel mechanism showing how a certain gene mutation can allow tumors to evade detection by the immune system in colorectal cancer patients.

Read More

Hollings Researcher Finds Surprising Results in COVID-19-Positive Lung Cancer Patients

Hollings Researcher Finds Surprising Results in COVID-19-Positive Lung Cancer Patients

Hollings Cancer Center
October 29th 2021

MUSC Hollings Cancer Center researcher and radiation oncologist Graham Warren, MD, PhD, published a new study in the Journal of Thoracic Oncology detailing new findings and early markers of COVID-19 in lung cancer patients.

Read More

Cancer Phase I Trials Expert Carolyn D. Britten, MD, Named Director of Hematology/Oncology Division for Medical University of South Carolina

Cancer Phase I Trials Expert Carolyn D. Britten, MD, Named Director of Hematology/Oncology Division for Medical University of South Carolina

Hollings Cancer Center
July 7th 2015

Britten continues as Associate Director for Clinical Investigations for the MUSC Hollings Cancer Center.

Read More

Latest Updated Articles

Sarwish Rafiq, PhD
Published: July 9th 2024 | Updated: July 10th 2024
Dr Rafiq on Novel Strategies for CAR T-Cell Engineering in Solid Tumors
Jens Hoeppner, FAChirg, FACS, MD
Published: June 2nd 2024 | Updated: June 3rd 2024
Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Published: July 25th 2024 | Updated: July 27th 2024
Dr Rotow on the Impact of Biomarker Testing on NSCLC Treatment Outcomes
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Published: July 25th 2024 | Updated: July 27th 2024
Dr Sabari on Barriers to Biomarker Testing in NSCLC
5 KOLs are featured in this series.
Published: July 18th 2024 | Updated: July 27th 2024
Treatment Considerations and Patient Selection for CAR T-cell Therapy in R/R ALL
5 KOLs are featured in this series.
Published: July 18th 2024 | Updated: July 27th 2024
Expert Insights on ZUMA-3 Data Updates: 4-Year Follow-up and Real World Data